BALYASNY ASSET MANAGEMENT L.P. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,586
-99.0%
762
-98.5%
0.00%
-100.0%
Q3 2022$2,781,000
-10.5%
49,689
+28.3%
0.01%
-40.0%
Q1 2021$3,107,000
-31.4%
38,720
-53.5%
0.02%
-40.0%
Q4 2020$4,526,000
+382.5%
83,193
+45.1%
0.02%
+316.7%
Q2 2019$938,000
+20.3%
57,321
+25.6%
0.01%
+20.0%
Q1 2019$780,000
+21.9%
45,646
-2.7%
0.01%0.0%
Q4 2018$640,00046,9110.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders